5 Smaller Biotechs That are Flying Under-the-Radar
These companies are important to follow as they have exponential growth potential and are working on new and innovative drugs. Source: BioSpace
These companies are important to follow as they have exponential growth potential and are working on new and innovative drugs. Source: BioSpace
As 2018 winds down, it's not over for some biopharma companies. Source: BioSpace
Cox takes over for Vital Therapies CEO Terry Winters who will step down from the Vital Therapies Board and become a consultant to the company. Source: BioSpace
Avanir terminated about 11 percent of its sales force after CNN filed a report showing how the company paid 500 prescribers about $14M over three years for prescribers to tout…
The company wants staffers to get a taste of life with a super-rare metabolic disorder. An actual taste. Source: BioSpace
Under the deal, Carmot will use its lead-identification technology to identify and advance novel drug leads for Parkinson's disease and other disease areas. Source: BioSpace
Amazon didn't immediately respond to a request for comment. Source: BioSpace
Goldfinch Bio continues to expand its leadership team. Source: BioSpace
The Series A was led by GV, with participation from AtlasVenture, Takeda Ventures, Vertex Ventures HC, Amgen Ventures, Alexandria Venture Investments, and ShangPharma Group. Source: BioSpace
According to the report, Isaly made lewd comments to female employees, subjected them to pornographic images and made "pervasive sexist comments." Source: BioSpace